A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn's Disease

被引:2
|
作者
Irwin, James [1 ,2 ,3 ]
Lord, Anton [1 ]
Ferguson, Emma [2 ]
Simms, Lisa A. [1 ]
Hanigan, Katherine [1 ]
Montoya, Carlos A. [4 ,5 ]
Radford-Smith, Graham [1 ,2 ,6 ]
机构
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[3] Palmerston North Hosp, Dept Gastroenterol, 50 Ruahine St, Palmerston North 4442, New Zealand
[4] AgResearch Ltd, Te Ohu Rangahau Kai Facil, Smart Foods Innovat Ctr Excellence, Palmerston North 4474, New Zealand
[5] Massey Univ, Riddet Inst, Te Ohu Rangahau Kai Facil, Palmerston North 4474, New Zealand
[6] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia
关键词
Biomarkers; Crohn's disease; Inflammatory bowel diseases; Stenosis; Perforation; Fistula; MAINTENANCE THERAPY; NATURAL-HISTORY; INDUCTION; RESECTION; COHORT; METHOTREXATE; PROGRESSION; ADALIMUMAB; REMISSION; SURGERY;
D O I
10.1007/s10620-022-07639-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Stenosis, fistulization, and perforation of the bowel are severe outcomes which can occur in patients with Crohn's disease. Accurate prediction of these events may enable clinicians to alter treatment strategies and avoid these outcomes. Aims To study the correlation between longitudinal laboratory testing and subsequent intestinal complications in patients with Crohn's disease. Methods An observational cohort of patients with Crohn's disease at a single center were analyzed between 01/01/1994 and 06/30/2016. A complication was defined as the development of an intestinal fistula, stenosis, or perforation. Exploratory analysis using Cox regression was performed to select the best statistical method to represent longitudinal laboratory data. Cox regression was used to identify laboratory variables independently associated with the development of a subsequent complication. A clinical scoring tool was designed. Results In 246 patients observed over a median of 5.72 years, 134 complications occurred. Minimum or maximum value in a preceding window period of one year was most strongly associated with subsequent complication. A Longitudinal Laboratory score of >= 2 (maximum albumin level < 39 g/L = 1, maximum mean cell volume < 88 fL = 1, minimum platelet count > 355 x 10(9)/L = 1, minimum C reactive protein > 5 mg/L = 1) was 62% sensitive and 91% specific in identifying patients who develop a subsequent complication. Conclusion A consistent reduction in serum albumin and mean cell volume, and a consistent increase in platelet count and C reactive protein were associated with a subsequent complication in patients with Crohn's disease. Longitudinal laboratory tests may be used as described in this paper to provide a rational for earlier escalation of therapy.
引用
收藏
页码:596 / 607
页数:12
相关论文
共 50 条
  • [21] INTESTINAL ULTRASOUND - ENVISIONING A NEW FUTURE FOR CROHN'S DISEASE MANAGEMENT
    Randhawa, Amrik
    Guzowski, Tomasz
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB73 - AB74
  • [22] The Diagnosis of Intestinal Fibrosis in Crohn's Disease-Present and Future
    Jarmakiewicz-Czaja, Sara
    Gruszecka, Jolanta
    Filip, Rafal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [23] Characteristics of the Kono-S anastomosis in Crohn's disease patients using intestinal ultrasound
    Low, Elizabeth S. L.
    Greeve, Tessa
    Boyapati, Ray K.
    Moore, Gregory T.
    Shelton, Edward
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (09) : 1150 - 1152
  • [24] A simple method for assessing intestinal inflammation in Crohn's disease
    Tibble, J
    Teahon, K
    Thjodleifsson, B
    Roseth, A
    Sigthorsson, G
    Bridger, S
    Foster, R
    Sherwood, R
    Fagerhol, M
    Bjarnason, I
    GUT, 2000, 47 (04) : 506 - 513
  • [25] MRI neurophenotype reflecting brain-gut interactions to predict intestinal disease progression in patients with Crohn's disease
    Zhang, R.
    Shen, X.
    Huang, L.
    Feng, S. T.
    Mao, R.
    Li, X.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1119 - i1119
  • [26] Pulmonary actinomycosis coexisting with intestinal tuberculosis as a complication of adalimumab treatment for Crohn's disease
    Aleric, I.
    Katalinic, D.
    Vcev, A.
    Brinar, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2017, 80 (04) : 544 - 546
  • [27] USING CLINICAL ROUTINE DATA TO PREDICT PRIMARY RESPONSE TO INFLIXIMAB THERAPIES IN CROHN'S DISEASE
    Ye, Xiaoqi
    Zhang, Sheng-Hong
    Cai, Jing
    Yu, Qiao
    Cao, Xiaocang
    Cao, Qian
    Chen, Minhu
    GASTROENTEROLOGY, 2020, 158 (06) : S955 - S955
  • [28] INTEGRATION OF MULTI-OMICS DATA USING MACHINE LEARNING TO PREDICT CROHN'S DISEASE
    Boodaghidizaji, Miad
    Haritunians, Talin
    Mcgovern, Dermot P. B.
    Li, Dalin
    GASTROENTEROLOGY, 2024, 166 (05) : S1406 - S1407
  • [29] Anti-glycan antibody seropositivity at diagnosis does not predict future disease course in patients with Crohn's disease
    Lyons, P.
    Noor, N.
    Lee, J. C.
    McKinney, E. F.
    Parkes, M.
    Smith, K. G. C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S278 - S278
  • [30] Intestinal permeability fluctuates in spouses of patients with Crohn's disease
    Breslin, NP
    Nash, C
    Hilsden, RJ
    Hershfield, NB
    Price, LM
    Meddings, JB
    Sutherland, LR
    GASTROENTEROLOGY, 1999, 116 (04) : A673 - A673